AspirinAnti-Inflammatory Agents, Non-SteroidalIbuprofenCyclooxygenase InhibitorsCyclooxygenase 2 InhibitorsNaproxenDiclofenacPlatelet Aggregation InhibitorsSulindacFlurbiprofenProstaglandin-Endoperoxide SynthasesIndomethacinPiroxicamCyclooxygenase 1Cyclooxygenase 2AcetaminophenKetoprofenSalicylatesThromboxane B2EtodolacTolmetinSodium SalicylatePyrazolesSulfonamidesTiclopidineThiazinesPlatelet AggregationDose-Response Relationship, DrugDrug Therapy, CombinationStomach UlcerGastrointestinal HemorrhageKetorolacDinoprostoneGastrointestinal DiseasesPhenylbutazoneProstaglandinsGrowth Differentiation Factor 15NitrobenzenesAnalgesics, Non-NarcoticPlatelet Function TestsSulfonesAnti-Inflammatory AgentsRisk FactorsFenoprofenDrug HypersensitivityLactonesIsoenzymesAsthma, Aspirin-InducedDrug InteractionsGastric MucosaDouble-Blind MethodStereoisomerismAnticarcinogenic AgentsPeptic Ulcer HemorrhageChemopreventionAnalgesicsBlood PlateletsThromboxanesDiflunisalTropaeolaceaeTime FactorsProspective StudiesWarfarinAnticoagulantsOxyphenbutazoneNonsteroidal Anti-AndrogensPeptic UlcerFibrinolytic AgentsProstaglandin AntagonistsTreatment OutcomeClonixinCase-Control StudiesLipoxinsMolecular StructureButanonesHemorrhageTablets, Enteric-CoatedSalicylic AcidModels, MolecularColorectal NeoplasmsPhenylpropionatesMagnetic Resonance SpectroscopyAromatase InhibitorsArthritisMefenamic AcidBleeding TimeMembrane ProteinsColonic NeoplasmsPlatelet ActivationArachidonic AcidMolecular Conformation6-Ketoprostaglandin F1 alphaKetorolac TromethamineFlutamideEstrogen AntagonistsAdenomatous PolypsAnti-Ulcer AgentsThromboxane A2UlcerMyocardial Infarction